Lumír Kunovský: Novel tool to treat neuroendocrine tumors of the pancreas
Lumír Kunovský,
“Novel tool to treat neuroendocrine tumors of the pancreas. What will the future hold? Surgery or endoscopy therapy? See below the results of the studies. More data will be presented at ESGE Days 2024.
Merci beaucoup Marseille for the EUS radiofrequency ablation course.
EUS-guided radiofrequency ablation for pancreatic insulinoma. Management of pancreatic NETs <2 cm by EUS-RFA seems to be effective with an acceptable safety profile. Read in Gastrointestinal Endoscopy journal.
Radiofrequency ablation for the management of symptomatic pancreatic insulinomas. Patients’ blood glucose trends in relation to timing of EUS-guided RFA. No hypoglycemia was seen during follow-up. Read in Gastrointestinal Endoscopy journal.
Risk factors for EUS-guided RFA adverse events in patients with pancreatic neoplasms. Proximity of pancreatic neoplasms (≤1 mm) to the main pancreatic duct was the only independent risk factor for AEs (OR 4.10, P = .04). Read in Gastrointestinal Endoscopy journal.
EUS-guided radiofrequency ablation of pancreatic/peripancreatic tumors and oligometastatic disease. Technical success: 100 % Complications: 10.3% Mild Acute Pancreatitis. Read in the Endoscopy Journal.”
Link to video.
Source: Lumír Kunovský/X
About OncoDaily
OncoDaily was founded in 2023. It is a US-based oncology media platform, which features the latest news, insights, and patient stories from the world of oncology. Within a short period of time it became one of the leading oncology media platforms globally.
OncoDaily gathers content from various sources, including social media posts from renowned oncologists from all over the world, news from oncology societies and cancer centers, patient and survivor stories, and career-related information for professionals.
The mission of OncoDaily is to empower patients, survivors, and professionals with the knowledge and inspiration they need to fight cancer. The motto of OncoDaily is “Cancer doesn’t take a day off – neither do we.”